The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer
K Vermeulen, DR Van Bockstaele… - Cell …, 2003 - Wiley Online Library
The cell cycle is controlled by numerous mechanisms ensuring correct cell division. This
review will focus on these mechanisms, ie regulation of cyclin‐dependent kinases (CDK) by …
review will focus on these mechanisms, ie regulation of cyclin‐dependent kinases (CDK) by …
Cyclin-dependent kinase-2 as a target for cancer therapy: progress in the development of CDK2 inhibitors as anti-cancer agents
TA Chohan, H Qian, Y Pan… - Current medicinal …, 2015 - ingentaconnect.com
Cyclin-dependent kinase-2 (CDK2) is a member of protein kinase family. It plays an
important role in regulating various events of eukaryotic cell division cycle. Accumulated …
important role in regulating various events of eukaryotic cell division cycle. Accumulated …
N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5- (tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine, a Novel, Highly Selective, Orally …
LF Hennequin, J Allen, J Breed, J Curwen… - Journal of medicinal …, 2006 - ACS Publications
Src family kinases (SFKs) are nonreceptor tyrosine kinases that are reported to be critical for
cancer progression. We report here a novel subseries of C-5-substituted anilinoquinazolines …
cancer progression. We report here a novel subseries of C-5-substituted anilinoquinazolines …
Microwave-assisted synthesis–catalytic applications in aqueous media
The development of sustainable methods directed towards the synthesis of molecules is due
to the heightened awareness and recognition of alternative eco-friendly and economical …
to the heightened awareness and recognition of alternative eco-friendly and economical …
Purine-based Schiff base Co (II), Cu (II), and Zn (II) complexes: Synthesis, characterization, DFT calculations, DNA binding study, and molecular docking
A series of metal complexes of Co (II), Zn (II), and Cu (II) of purine base Schiff base ligand L
1 6, 6′-((1E, 1′ E)-((7H-purine-2, 6-diyl) bis (azanylylidene)) bis (methanylylidene)) bis (2 …
1 6, 6′-((1E, 1′ E)-((7H-purine-2, 6-diyl) bis (azanylylidene)) bis (methanylylidene)) bis (2 …
[HTML][HTML] Synthesis, spectral, antitumor and antimicrobial studies on Cu (II) complexes of purine and triazole Schiff base derivatives
S Amer, N El-Wakiel, H El-Ghamry - Journal of Molecular Structure, 2013 - Elsevier
A series of copper (II) complexes of Schiff bases derived from 7H-2, 6-diaminopurine and 4H-
3, 5-diamino-1, 2, 4-triazole with 2-pyridinecarbaldehyde, salicylaldehyde, 2, 4 …
3, 5-diamino-1, 2, 4-triazole with 2-pyridinecarbaldehyde, salicylaldehyde, 2, 4 …
Structure-based design of a potent purine-based cyclin-dependent kinase inhibitor
TG Davies, J Bentley, CE Arris, FT Boyle… - Nature structural …, 2002 - nature.com
Aberrant control of cyclin-dependent kinases (CDKs) is a central feature of the molecular
pathology of cancer. Iterative structure-based design was used to optimize the ATP …
pathology of cancer. Iterative structure-based design was used to optimize the ATP …
Cyclin-dependent kinase (CDK) inhibitors: structure–activity relationships and insights into the CDK-2 selectivity of 6-substituted 2-arylaminopurines
Purines and related heterocycles substituted at C-2 with 4′-sulfamoylanilino and at C-6
with a variety of groups have been synthesized with the aim of achieving selectivity of …
with a variety of groups have been synthesized with the aim of achieving selectivity of …
Knowledge based prediction of ligand binding modes and rational inhibitor design for kinase drug discovery
AK Ghose, T Herbertz, DA Pippin… - Journal of medicinal …, 2008 - ACS Publications
Drug discovery is a complex and lengthy endeavor. 1 Many strategies exist to accelerate
target-to-clinical candidate selection, as well as to provide the highest quality candidate …
target-to-clinical candidate selection, as well as to provide the highest quality candidate …
Fragment-based de novo ligand design by multiobjective evolutionary optimization
F Dey, A Caflisch - Journal of chemical information and modeling, 2008 - ACS Publications
GANDI (G enetic A lgorithm-based de N ovo D esign of I nhibitors) is a computational tool for
automatic fragment-based design of molecules within a protein binding site of known …
automatic fragment-based design of molecules within a protein binding site of known …